Toolkit/HPLC-DAD
HPLC-DAD
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Finally, quercetin and abscisic acid were quantified to complete the data by HPLC-DAD.
Usefulness & Problems
Why this is useful
HPLC-DAD was used to quantify quercetin and abscisic acid in the dried Juglans regia extract. In this paper it serves as a chemical validation method rather than a biological assay.; quantifying selected compounds in the extract
Source:
HPLC-DAD was used to quantify quercetin and abscisic acid in the dried Juglans regia extract. In this paper it serves as a chemical validation method rather than a biological assay.
Source:
quantifying selected compounds in the extract
Problem solved
It helps complete the dataset by measuring the abundance of selected candidate bioactive compounds in the extract.; provides targeted chemical quantification to complement bioactivity and docking data
Source:
It helps complete the dataset by measuring the abundance of selected candidate bioactive compounds in the extract.
Source:
provides targeted chemical quantification to complement bioactivity and docking data
Problem links
provides targeted chemical quantification to complement bioactivity and docking data
LiteratureIt helps complete the dataset by measuring the abundance of selected candidate bioactive compounds in the extract.
Source:
It helps complete the dataset by measuring the abundance of selected candidate bioactive compounds in the extract.
Published Workflows
Objective: Evaluate the anti-inflammatory potential of Juglans regia fresh fruit extract in acute and chronic inflammatory states in vivo and complement the in vivo findings with in silico target-binding analysis and targeted chemical quantification.
Why it works: The workflow combines organism-level anti-inflammatory readouts with in silico binding hypotheses and targeted quantification of named constituents to connect observed activity with candidate compounds and targets.
Stages
- 1.In vivo anti-inflammatory assay evaluation(functional_characterization)
This stage tests whether the extract shows anti-inflammatory activity in acute and chronic inflammatory states in vivo.
Selection: Measure anti-inflammatory and pain-related responses of the extract in zymosan-induced edema, zymosan-induced thermal hyperalgesia, and formalin assays.
- 2.In silico docking analysis(secondary_characterization)
This stage provides candidate mechanistic support for the observed anti-inflammatory activity by identifying compounds with favorable docking to selected targets.
Selection: Assess binding of named compounds to AChE, BChE, and glucocorticoid receptor by docking.
- 3.Targeted compound quantification by HPLC-DAD(confirmatory_validation)
This stage completes the dataset by confirming the presence and abundance of selected compounds highlighted in the study.
Selection: Quantify quercetin and abscisic acid in the dried extract by HPLC-DAD.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Techniques
Functional AssayTarget processes
No target processes tagged yet.
Implementation Constraints
It requires dried extract samples and HPLC-DAD instrumentation.; requires dried extract material; requires HPLC-DAD instrumentation
The abstract does not show that HPLC-DAD alone identifies all active constituents or proves mechanism of action.; the abstract supports quantification of only two named compounds
Validation
Supporting Sources
Ranked Claims
HPLC-DAD quantified abscisic acid at 0.036 ± 0.004 mg/g of dried extract.
quercetin and abscisic acid were quantified to complete the data by HPLC-DAD, giving 0.246 ± 0.003 mg/g of dried extract and 0.036 ± 0.004 mg/g of dried extract, respectively.
HPLC-DAD quantified quercetin at 0.246 ± 0.003 mg/g of dried extract.
quercetin and abscisic acid were quantified to complete the data by HPLC-DAD, giving 0.246 ± 0.003 mg/g of dried extract and 0.036 ± 0.004 mg/g of dried extract, respectively.
Approval Evidence
Finally, quercetin and abscisic acid were quantified to complete the data by HPLC-DAD.
Source:
HPLC-DAD quantified abscisic acid at 0.036 ± 0.004 mg/g of dried extract.
quercetin and abscisic acid were quantified to complete the data by HPLC-DAD, giving 0.246 ± 0.003 mg/g of dried extract and 0.036 ± 0.004 mg/g of dried extract, respectively.
Source:
HPLC-DAD quantified quercetin at 0.246 ± 0.003 mg/g of dried extract.
quercetin and abscisic acid were quantified to complete the data by HPLC-DAD, giving 0.246 ± 0.003 mg/g of dried extract and 0.036 ± 0.004 mg/g of dried extract, respectively.
Source:
Comparisons
Source-stated alternatives
No alternative quantification platform is named in the abstract.
Source:
No alternative quantification platform is named in the abstract.
Source-backed strengths
used to quantify quercetin and abscisic acid in the dried extract
Source:
used to quantify quercetin and abscisic acid in the dried extract
Compared with Langendorff perfused heart electrical recordings
HPLC-DAD and Langendorff perfused heart electrical recordings address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
Compared with native green gel system
HPLC-DAD and native green gel system address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
HPLC-DAD and sub-picosecond pump-probe analysis of bacteriorhodopsin pigments address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
Ranked Citations
- 1.